Table 2.
Patient number | Location | GTV | CTV margin (cm) | PTV margin (cm) | PTV volume (cm3) | Type | Number of fractions planned | Total dose planned (cGy) | Number of fractions delivered | Completed radiation |
---|---|---|---|---|---|---|---|---|---|---|
1 | Enhancing | 2 + FLAIR | 0.3 | 667 | IMRT | 15 | 3750 | 15 | Y | |
2 | FLAIR + enhancing | 0.5 | 0.3 | 487 | IMRT | 20 | 4000 | 20 | Y | |
3 | Enhancing | 2.5 + FLAIR | 0.3 | 398 | IMRT | 20 | 4000 | 20 | Y | |
4 | FLAIR + enhancing | 1 | 0.3 | 398 | IMRT | 15 | 3750 | 15 | Y | |
5 | FLAIR + enhancing | 1 | 0.3 | 397 | IMRT | 20 | 4000 | 13 | N | |
6 | Enhancing | 1 | 0.3 | 195 | IMRT | 15 | 3750 | 15 | Y | |
7 | FLAIR + enhancing | 0 | 0.5 | 225 | IMRT | 15 | 3750 | 15 | Y | |
8 | FLAIR + enhancing | 0 | 0.5 | 145 | IMRT | 20 | 4000 | 20 | Y | |
9 | Enhancing mass | 0.5 | 0 | 36 | IMRT | 15 | 3750 | 15 | Y | |
10 | Enhancing | 0.5 | 0.3 | 190 | IMRT | 15 | 3750 | 15 | Y | |
11 | FLAIR + enhancing | 1 | 0.3 | 442 | VMAT | 15 | 3750 | 15 | Y | |
12 | Enhancing | 0 | 0.3 | 148 | IMRT | 10 | 3500 | 10 | Y | |
13 | Enhancing | 0 | 0.3 | 181 | VMAT | 15 | 3750 | 15 | Y | |
14 | Enhancing | 1 | 0.3 | 245 | IMRT | 22 | 4400 | 22 | Y | |
15 | FLAIR + enhancing | 0 | 0.3 | 394 | IMRT | 15 | 3750 | 5 | N | |
16 | FLAIR + enhancing | 0 | 0.3 | 216 | IMRT | 15 | 3750 | 15 | Y | |
17 | FLAIR + enhancing | 1 | 0.7 | 443 | VMAT | 30 | 5400 | 5 | N | |
18 | FLAIR + enhancing | 0 | 0.3 | 81.4 | IMRT | 15 | 3750 | 15 | Y | |
19 | FLAIR + enhancing | 0 | 0.3 | 100 | VMAT | 15 | 3750 | 15 | Y | |
20 | FLAIR + enhancing | 0 | 0.3 | 118 | VMAT | 15 | 3750 | 2 | N | |
21* | Splenium | FLAIR + enhancing | 0 | 0.3 | 34 | VMAT | 14 | 3500 | 9 | N |
21 | Brachium pontis | FLAIR + enhancing | 0 | 0.1 | 0.3 | SRS | 5 | 2000 | 2 | N |
22 | Enhancing | 0.5 | 0.3 | 112 | VMAT | 15 | 3750 | 15 | Y |
KEY: IMRT static field intensity modulated radiation therapy, VMAT volumetric modulated arc therapy, SRS stereotactic radiosurgery, FLAIR fluid attenuation inversion recovery
*Patient 21 had two separate lesions radiated in two discontiguous fields on trial. All other patients had one contiguous radiation field